BRTX – biorestorative therapies, inc. (US:NASDAQ)
Stock Stats
News
Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript [Seeking Alpha]
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
Form SCHEDULE 13G/A BioRestorative Therapies Filed by: Morrison Todd Hale
Form 424B3 BioRestorative Therapies
Form EFFECT BioRestorative Therapies
Form S-8 BioRestorative Therapies
Form S-1 BioRestorative Therapies
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.